SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-018501
Filing Date
2020-04-24
Accepted
2020-04-24 16:11:36
Documents
3
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A crsp-defa14a_20200611.htm DEFA14A 47994
2 GRAPHIC g5z3hhkkiy2z000002.jpg GRAPHIC 151232
3 GRAPHIC g5z3hhkkiy2z000001.jpg GRAPHIC 109186
  Complete submission text file 0001564590-20-018501.txt   407940
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37923 | Film No.: 20815062
SIC: 2836 Biological Products, (No Diagnostic Substances)